Top 10 Companies in the 1,1‑Cyclopropanediacetonitrile (CAS 20778‑47‑6) Market (2026): Market Leaders Powering Global Innovation

MARKET INSIGHTS

Global 1,1‑Cyclopropanediacetonitrile (CAS 20778‑47‑6) market size was valued at USD 28.4 million in 2025. The market is projected to grow from USD 30.1 million in 2026 to USD 52.6 million by 2034, exhibiting a CAGR of 7.2% during the forecast period.

1,1‑Cyclopropanediacetonitrile is a specialized organic compound featuring a cyclopropane ring substituted with two acetonitrile groups at the 1,1‑position. It serves as a versatile chemical intermediate, primarily utilized in the synthesis of pharmaceuticals, agrochemicals, and fine chemical formulations. Its unique bicyclic and nitrile‑bearing structure makes it particularly valuable in the development of complex molecular scaffolds used in medicinal chemistry research and active pharmaceutical ingredient (API) manufacturing.

The market is witnessing steady growth driven by rising demand for advanced pharmaceutical intermediates and the expanding scope of agrochemical research globally. The increasing focus on drug discovery programs and the growing need for structurally diverse building blocks in synthetic chemistry are key factors propelling adoption. Furthermore, advancements in cyclopropane‑based chemistry and the broadening application of dinitrile compounds in specialty chemical synthesis continue to open new avenues for market participants operating across North America, Europe, and Asia‑Pacific.

1,1‑Cyclopropanediacetonitrile (CAS 20778‑47‑6) Market – View in Detailed Research Report

Top 10 Companies Driving Market Growth

1️⃣ Hairui Fine Chemicals Co., Ltd.

Headquarters: Guangzhou, China
Key Offering: GMP‑grade 1,1‑Cyclopropanediacetonitrile for API synthesis

Hairui Fine Chemicals has built a reputation for delivering high‑purity intermediates to pharmaceutical developers. Its state‑of‑the‑art purification units consistently achieve >99% purity, aligning with the stringent requirements of early‑stage drug discovery programs. The company’s focus on scalable cyclopropane chemistry positions it as a preferred partner for projects targeting CNS disorders and enzyme inhibitors.

Sustainability & Growth Initiatives:

• Renewable feedstock sourcing for cyclopropane precursors
• Closed‑loop waste minimisation in purification processes
• Continuous investment in process intensification technologies

2️⃣ Capot Chemical Co., Ltd.

Headquarters: Shenzhen, China
Key Offering: High‑purity 1,1‑Cyclopropanediacetonitrile for fine‑chemical synthesis

Capot Chemical specialises in custom synthesis services for agrochemical and fine‑chemical manufacturers. The firm maintains a robust supply chain that supports rapid turnaround times, making it an attractive source for contract research and manufacturing organizations (CRAM/CDMO) looking to incorporate cyclopropane motifs into next‑generation herbicides and fungicides.

Sustainability & Growth Initiatives:

• Green chemistry protocols to reduce solvent usage
• Partnerships with regional universities for catalyst development
• Expansion of on‑site analytical capabilities for real‑time quality control

3️⃣ Hebei Guanlang Biotechnology Co., Ltd.

Headquarters: Shijiazhuang, China
Key Offering: Custom 1,1‑Cyclopropanediacetonitrile for pharmaceutical intermediates

Hebei Guanlang Biotechnology delivers tailored intermediates to pharmaceutical R&D labs, focusing on projects that require rapid synthesis of complex cyclopropane‑based scaffolds. The company’s flexible production model allows for small‑batch, high‑purity runs that meet the demands of emerging drug candidates.

Sustainability & Growth Initiatives:

• Implementation of energy‑efficient reactors
• Adoption of biodegradable solvents in downstream processing
• Collaborative R&D with academic institutions on green cyclopropanation methods

4️⃣ Matrix Scientific

Headquarters: New York, USA
Key Offering: High‑purity 1,1‑Cyclopropanediacetonitrile for medicinal chemistry research

Matrix Scientific serves a global portfolio of research laboratories, providing high‑purity intermediates that support fragment‑based drug discovery and structure‑activity relationship studies. The company’s catalog emphasizes rapid synthesis and strict quality controls, making it a go‑to supplier for academic and biotech startups.

Sustainability & Growth Initiatives:

• Investment in continuous‑flow synthesis platforms
• Supplier‑managed waste reduction programmes
• Transparent safety data sheets compliant with GHS standards

5️⃣ Wuhan Fortuna Chemical Co., Ltd.

Headquarters: Wuhan, China
Key Offering: Large‑scale production of 1,1‑Cyclopropanediacetonitrile for agrochemical applications

Wuhan Fortuna Chemical has scaled its production to meet the growing demand for cyclopropane‑containing agrochemicals. The firm’s integrated supply chain reduces lead times, supporting the rapid development of next‑generation herbicides and insecticides that leverage the metabolic stability of the strained ring system.

Sustainability & Growth Initiatives:

• Adoption of renewable energy sources for plant operations
• Process optimisation to lower raw‑material consumption
• Strategic alliances with raw‑material suppliers for secure feedstock supply

6️⃣ Shanghai Aladdin Biochemical Technology Co., Ltd.

Headquarters: Shanghai, China
Key Offering: High‑purity 1,1‑Cyclopropanediacetonitrile for fine‑chemical and specialty‑chemical synthesis

Shanghai Aladdin Biochemical Technology provides a range of high‑purity intermediates to the fine‑chemical sector. Its advanced chromatographic purification and real‑time monitoring ensure consistency, which is critical for contract manufacturers producing complex organic molecules.

Sustainability & Growth Initiatives:

• Implementation of closed‑loop solvent recovery systems
• Use of biocatalysts for selective transformations
• Collaboration with industry consortia to develop greener cyclopropanation routes

7️⃣ Enamine Ltd.

Headquarters: Kyiv, Ukraine
Key Offering: Commercial 1,1‑Cyclopropanediacetonitrile for medicinal chemistry libraries

Enamine’s catalog focuses on providing intermediates that enable rapid library synthesis for drug discovery. The company’s emphasis on high‑purity reagents and detailed safety documentation makes it a reliable source for academic and industrial research.

Sustainability & Growth Initiatives:

• Development of low‑toxicity purification protocols
• Engagement with European regulatory bodies to streamline approvals
• Investment in digital platforms for supplier‑customer collaboration

8️⃣ Anhui Wokai Biotechnology Co., Ltd.

Headquarters: Hefei, China
Key Offering: Custom synthesis of 1,1‑Cyclopropanediacetonitrile for pharmaceutical intermediates

Anhui Wokai Biotechnology tailors production runs to meet the specific needs of pharmaceutical developers, offering flexible batch sizes and rapid delivery. The firm’s process expertise supports the synthesis of complex cyclopropane‑based APIs.

Sustainability & Growth Initiatives:

• Implementation of energy‑efficient reaction vessels
• Partnerships with universities to explore novel cyclopropane chemistry
• Continuous improvement of waste‑to‑resource conversion processes

9️⃣ Shandong Baimao Huiyuan Bio‑Technology Co., Ltd.

Headquarters: Qingdao, China
Key Offering: High‑purity 1,1‑Cyclopropanediacetonitrile for fine‑chemical and agrochemical synthesis

Shandong Baimao Huiyuan Bio‑Technology supplies intermediates to both fine‑chemical manufacturers and agrochemical companies. The firm’s focus on quality assurance and rapid turnaround supports the development of next‑generation active ingredients.

Sustainability & Growth Initiatives:

• Adoption of renewable feedstocks for cyclopropane synthesis
• Investment in green solvent technologies
• Collaboration with industry partners to standardise safety protocols

🔟 Hebei Mojin Biotechnology Co., Ltd.

Headquarters: Tangshan, China
Key Offering: Custom 1,1‑Cyclopropanediacetonitrile for pharmaceutical and agrochemical R&D

Hebei Mojin Biotechnology provides bespoke intermediates for research laboratories and contract manufacturers. The company’s flexible production model and stringent quality controls make it a trusted partner for projects requiring high‑purity cyclopropane reagents.

Sustainability & Growth Initiatives:

• Implementation of energy‑saving catalytic processes
• Use of recyclable materials in packaging
• Engagement with regulatory agencies to streamline product approvals

Download FREE Sample Report

Get Full Report Here

Outlook

Over the next decade, the 1,1‑Cyclopropanediacetonitrile market is expected to continue expanding, driven by the persistent demand for complex molecular scaffolds in drug discovery and the growing emphasis on sustainable agrochemical development. The concentration of production in China, coupled with the increasing capabilities of regional players in India and the United States, will shape supply dynamics and pricing structures. Companies that invest in scalable, green synthesis routes and robust safety infrastructure will be best positioned to capture emerging opportunities in both pharmaceutical and agrochemical segments.

Future Trends

• Integration of continuous‑flow chemistry for cyclopropane synthesis, reducing energy consumption and waste.
• Expansion of digital platforms that enable rapid procurement and real‑time quality tracking for specialty intermediates.
• Development of novel cyclopropane‑based polymers and energetic materials, opening new markets beyond traditional pharmaceuticals.
• Increased collaboration between academia and industry to accelerate the discovery of new cyclopropane scaffolds with improved pharmacokinetic properties.
• Regulatory harmonisation efforts that streamline approval pathways for intermediates used in global drug pipelines.